When a stock goes through a prolonged down cycle as we have witnessed here with DRAD, the investment community tends to lose interest. Drad has been down now for several years, and by all recent measures, very few investors have noticed the positive potential going forward. The last quareterly report and conference call, Q4/2010, should have been an eye opener, but when nobody is paying attention, the stock simply gets un-noticed and drifts. I took an initial position in DRAD during early March with 5,000 shares at $2.62. I've been buying on a periodic basis from that point to the present while these shares have continued to languish. I now have 20,000 shares built up with an average cost of $2.48/share. From my vantage point, I believe DRAD's operational fundamentals are going to show very nice improvement through this year and into 2012. I consider it to be a very "strong buy". This is the type of situation that will catch the vast numbers of investors by complete surprise. Buying into DRAD at this point with a strategy of accumulating and holding for the next 12 to 24 months should pay off very well. Its a true "buy low and sell high" type of situation. I highly recommend it to those who feel comfortable with it on a long term basis. The next few quarterly reports are sure to trigger some renewed interest. I suggest that anyone who might have interest here should read the last quarterly report, and by all means, listen to the conference call. What you want to do is to get ahead of the curve. As I mentioned in my last posting, the potential here is "gradually" evolving to the positive side from the highly negative and that ultimately will bring higher share pricing over an extended period.
i've been lonely on this message board for almost a year! the stock has done well for me, but there is much much more upside. cash flow positive companies don't rationally trade at 0.2x sales unless you think the entire business is going away.
with the new product launches coming this year and new partnerships, growth will be easily apparent and the stock will trade at a more reasonable multiple for healthcare companies (which is at least 1x!).
I could not agree more with you that DRAD at this point is a screaming very safe "strong buy". I anticipate some real nice share price growth through 2011 and into 2012 leading to a substantial multi-bagger. DRAD has finally got its act together and subsequent quarterly reports will clearly bring that to the attention of the investment community. The company is poised to "surprise" to the upside while the vast number of investors are currently unaware and looking in other directions. One look at the lack of posting frequency at this chatboard gives support to that belief. This is the type of situation that warms my heart. Its onward and upward from here with DRAD.